They also included NeuroD6 whose expression levels are reduced in Caucasian AD brains during progression of AD at fold change = 0.569 for the comparison between severe AD and NC (P = 0.0072, Table 3, italicized). The gene discussed is NEUROD6; the disease is Alzheimer disease.